Page last updated: 2024-08-16

ro 31-8220 and benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal

ro 31-8220 has been researched along with benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haskard, DO; Lidington, EA; Mason, JC1

Other Studies

1 other study(ies) available for ro 31-8220 and benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal

ArticleYear
Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury.
    Blood, 2000, Oct-15, Volume: 96, Issue:8

    Topics: CD55 Antigens; Cells, Cultured; Complement Activation; Complement System Proteins; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Feedback; Flavonoids; Gene Expression Regulation; Humans; Imidazoles; Indoles; Inflammation; Lymphokines; Maleimides; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; NF-kappa B; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Protein Kinase C; Protein Serine-Threonine Kinases; Pyridines; Receptor, PAR-1; Receptors, Thrombin; Recombinant Proteins; RNA, Messenger; Thrombin; Thrombosis; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000